Evidence map›Paper›PMID 41307081›Full record

ArticleAdvanced biomedical research2025

A Bibliometric Analysis of Drug Resistance in Pediatric Acute Lymphoblastic Leukemia.

Alireza Khanahmad, Mohammad Hossein Khazaee-Nasirabadi, Mahshid Lotfi, Amir Hami

Abstract read
In one paragraph

Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alireza KhanahmadStudent Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Mohammad Hossein Khazaee-NasirabadiDepartment of Medical Laboratory Sciences, School of Allied Medical Sciences, Jiroft University of Medical Sciences, Jiroft, Iran.
Mahshid LotfiResearch Center for Health Technology Assessment and Medical Informatics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Amir HamiDepartment of Medical Library and Information Sciences, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the improved outcomes in acute lymphoblastic leukemia (ALL), drug resistance remains a major challenge. This study provides the first overview of global research trends in pediatric ALL drug resistance, highlighting emerging directions. Materials and Methods: In this bibliometric study, related keywords such as acute lymphoblastic leukemia, pediatric, and drug resistance were searched in the Web of Science (WOS) Core Collection. The retrieved papers were subjected to bibliometric analysis and visualization using Biblioshiny and VOSviewer. Results: A total of 432 original papers and 94 review articles by 2546 researchers from 48 countries were analyzed. The United States contributed 148 articles, which received 9569 citations. Bradford's law identified nine core sources, with Conclusion: Medical researchers have been attracted to different aspects of drug resistance in pediatric ALL. This bibliometric analysis reflects the current state of research on drug resistance in pediatric ALL and draws attention to critical concerns that require further investigation.

Indexed as

Bibliometricsdrug resistanceneoplasmprecursor cell lymphoblastic leukemia-lymphoma

Identifiers

PMID41307081
PMCPMC12646343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.